Literature DB >> 30851374

Glycated Hemoglobin and the Risk of Sternal Wound Infection After Adult Cardiac Surgery: A Systematic Review and Meta-Analysis.

Fausto Biancari1, Salvatore Giordano2.   

Abstract

Increased glycated hemoglobin (HbA1c) has been shown to increase the risk of mortality, myocardial infarction, and stroke after cardiac surgery, whereas its impact on the development of sternal wound infection (SWI) is less clear. A systematic review and meta-analysis were performed to evaluate the impact of preoperative HbA1c levels on the occurrence of SWI after adult cardiac surgery. Fourteen studies including 17,609 patients fulfilled the inclusion criteria and were included in this analysis. Diagnostic test meta-analysis of studies evaluating baseline HbA1c cut-off values ranging from 6% to 7% DCCT units (42-53 mmol/mol IFCC units) showed that the diagnostic odds ratio for deep SWI was 3.02 (95% confidence interval [CI] 2.10-4.35), while the diagnostic odds ratio for any SWI was 2.81 (95% CI 2.02-3.93). Binary meta-analysis confirmed that baseline HbA1c cut-off values ranging from 6% to 7% increased the risk for deep SWI (pooled incidence 2.7% vs 0.8%, risk ratio [RR] 3.01, 95% CI 2.32-3.90, I2 0%). Six studies included only diabetics and their pooled RR for deep SWI was 2.94 (1.59-5.45, I2 0%). Nine studies evaluated an HbA1c cut-off value of 7% and their RR for deep SWI was 3.22 (95% CI 2.38-4.37, I2 0%). The RR for any SWI was 2.92 (95% CI 2.42-3.53, I2 0%). This pooled analysis showed that the risk of SWI is substantially increased when preoperative HbA1c levels are over 6-7%. Future studies should evaluate whether postponing surgery for optimization of the glycemic control can reduce the risk of SWI in patients with increased levels of HbA1c.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac surgery; Coronary artery bypass grafting; Glycated hemoglobin; Glycosylated hemoglobin; HbA1c; Sternal wound infection

Mesh:

Substances:

Year:  2019        PMID: 30851374     DOI: 10.1053/j.semtcvs.2019.02.029

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  6 in total

1.  Evaluation of the Effect of Comprehensive and Targeted Surveillance on Nosocomial Infections in Nephrology Patients.

Authors:  Jiali Zheng; Jiuying Fei; Hongbo Li; Yan Xu
Journal:  J Healthc Eng       Date:  2022-04-29       Impact factor: 3.822

2.  Obesity and Preoperative Anaemia as Independent Risk Factors for Sternal Wound Infection After Coronary Artery Bypass Graft Surgery with Pedicled (Non-Skeletonized) Internal Mammary Arteries: The Role of Thoracic Wall Ischemia?

Authors:  Yohan N'Guyen; Annick Lefebvre; Vito Giovanni Ruggieri; Sylvain Rubin; Aurélie Brunet; Anne Poncet; Ailsa Robbins; Odile Bajolet; Yves Saade
Journal:  Vasc Health Risk Manag       Date:  2020-12-15

3.  The impact of preoperative glycated hemoglobin (HbA1c) on postoperative complications after elective major abdominal surgery: a meta-analysis.

Authors:  Joanna K L Wong; Yuhe Ke; Yi Jing Ong; HuiHua Li; Ting Hway Wong; Hairil Rizal Abdullah
Journal:  Korean J Anesthesiol       Date:  2021-10-08

Review 4.  The Problem of Wound Healing in Diabetes-From Molecular Pathways to the Design of an Animal Model.

Authors:  Mateusz Mieczkowski; Beata Mrozikiewicz-Rakowska; Michał Kowara; Marcin Kleibert; Leszek Czupryniak
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

5.  Correlation between the Control of Blood Glucose Level and HbA1C and the Incidence of Surgical Site Infection after Emergent Surgery for the Lower Limb Fracture among Type II DM Patients Aged More Than 50 Years Old.

Authors:  Wei-Hung Wang; Tsung-Cheng Hsieh; Wen-Tien Wu; Ru-Ping Lee; Jen-Hung Wang; Kuang-Ting Yeh
Journal:  J Clin Med       Date:  2022-09-22       Impact factor: 4.964

6.  Impact of preoperative HbA1c on postoperative complications after elective major abdominal surgery: a systematic review protocol.

Authors:  Joanna Kae Ling Wong; Yuhe Ke; Yi Jing Ong; Hui Hua Li; Hairil Rizal Abdullah
Journal:  BMJ Open       Date:  2020-09-30       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.